...
首页> 外文期刊>British journal of anaesthesia >Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinal-epidural anaesthesia.
【24h】

Remifentanil for fetal immobilization and analgesia during the ex utero intrapartum treatment procedure under combined spinal-epidural anaesthesia.

机译:瑞芬太尼用于脊髓硬膜外麻醉下子宫内分娩治疗过程中的胎儿固定和镇痛。

获取原文
获取原文并翻译 | 示例

摘要

Remifentanil undergoes extensive placental transfer and has been used to provide fetal immobilization and anaesthesia for in utero fetal endoscopic interventions. We report three cases of the ex utero intrapartum treatment performed under neuraxial anaesthesia where the maternal administration of remifentanil was used to provide fetal immobilization and analgesia. Fetal pathology included goiter and arthrogryposis, with one case requiring a tracheostomy. The longest time on placental circulation was 21 min. No clinically significant maternal sedation or respiratory depression was observed. In all cases, remifentanil provided adequate fetal immobilization and obviated the need to administer other analgesics or neuromuscular blocking agents. Remifentanil is a useful adjunct for ex utero fetal procedures.
机译:瑞芬太尼接受广泛的胎盘移植,已被用于子宫内窥镜干预中的胎儿固定和麻醉。我们报告了三例在神经麻醉下进行的宫内分娩治疗的情况,其中母体给予瑞芬太尼用于提供胎儿固定和镇痛作用。胎儿病理包括甲状腺肿大和关节变态,其中一例需要气管切开术。胎盘循环时间最长为21分钟。没有观察到具有临床意义的孕妇镇静或呼吸抑制。在所有情况下,瑞芬太尼均能提供足够的胎儿固定作用,从而避免了使用其他止痛药或神经肌肉阻滞剂的需要。瑞芬太尼是宫内胎儿手术的有用辅助剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号